Swing Therapeutics
SAN FRANCISCO, CA, United States · Biotechnology · 22 employees
Swing Therapeutics was founded in 2019 with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to
Funding history
- Series seed — $3.3M — Sep 2025
- Funding Round — $11.4M — Aug 2025
- Funding Round — $10.3M — Jul 2022
- Funding Round — $9.2M — Jul 2022
- Series series a — $10.3M — Jun 2022
Recent signals
- Sep 15, 2025: Raised $3.3M in Series seed
- Aug 29, 2025: Raised $11.4M
- Jul 26, 2022: Raised $10.3M
- Jul 26, 2022: Raised $9.2M
- Jun 16, 2022: Raised $10.3M in Series series a
See plans & pricing → Track Swing Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.